Key result
CHA2DS2-VA score linked to ~119% higher in-hospital mortality per unit in acute aortic dissection.
Why the study?
Data were lacking in the literature regarding the effect of the CHA2DS2-VA score on in-hospital mortality in patients with acute aortic dissection.
Does the CHA2DS2-VA score predict in-hospital mortality in patients undergoing surgical treatment for acute aortic dissection?
Cohort (n=113)
Does the CHA2DS2-VA score predict in-hospital mortality in patients undergoing surgical treatment for acute aortic dissection?
The CHA2DS2-VA score can serve as an independent prognostic marker for predicting in-hospital mortality in patients with acute aortic dissection.
Answers are grounded in this paper and cite their sources.
CHA2DS2-VA may predict in-hospital mortality in acute aortic dissection; hypothesis-generating and leaves open prospective validation.
INTRODUCTION: he CHA2DS2-VA score, which is used to determine the risk of thromboembolism in patients with atrial fibrillation, has been shown to be a predictor of mortality in many cardiovascular diseases. However, there is no data in the literature on the effect of CHA2DS2-VA score on in-hospital mortality in patients with acute aortic dissection (AAD). We aimed to determine the effect of CHA2DS2-VA score on in-hospital mortality in patients with AAD. METHODS: This retrospective cohort study included 113 patients (89 males, 24 females, age 58.7±10.5 years) who underwent surgical treatment for AAD. CHA2DS2-VA scores were calculated. All cases of in-hospital mortality during the follow-up period were identified and recorded. Patients were grouped as with and without mortality. RESULTS: Among patients with AAD, in-hospital mortality was observed in 30 cases (27.5%). Mortality rates in patients with CHA2DS2-VA 1, 2, 3 and ≥ 4 were 7%, 13%, 27%, and 53%, respectively. Age, CHA2DS2-VA score, and high-sensitivity C-reactive protein serum level independently determined the patients with mortality, and each one unit increase in these parameters predicted 11.3%, 2.19-fold, and 3.2% mortality increase, respectively. In receiver operating characteristic analysis, when the cutoff value of CHA2DS2-VA score was taken as 3, it was found to determine the development of mortality due to AAD with 80.5% sensitivity and 78.6% specificity. CONCLUSION: CHA2DS2-VA score is independently associated with the development of in-hospital mortality in patients with AAD. According to the findings of our study, the CHA2DS2-VA score may serve as a prognostic marker in patients with AAD.
No takes yet. Share an insight, caveat, or question.
Ardıç et al. (2026) conducted a cohort in Acute Aortic Dissection (n=113). CHA2DS2-VA score was evaluated on In-hospital mortality (2.19-fold increase per unit). The CHA2DS2-VA score independently predicted in-hospital mortality in patients with acute aortic dissection, with each one-unit increase associated with a 2.19-fold increase in mortality.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: